DeFi funds: Renesis puts verified NAV on-chain via Enzyme

Thomas Pratter, founder of Renesis, says the problem is verification. A traditional fund's track record usually comes with sources an allocator can check. A DeFi book is different: looped positions and nested protocols make it hard for a traditional allocator to see how the numbers were built.

Pratter argues that for more institutional capital to come on-chain, allocators need the trust and verifiability to understand how those track records come together, and the confidence to allocate.

He saw the same issue from the inside. After six or seven years building algo trading systems on the institutional side, he concluded that funds struggle to put data into formats an allocator can understand and trust.

Today a fund manager has two routes for an investor report: do it alone or hand it to a fund admin. Doing it alone often means spreadsheets and retail DeFi trackers, stitched together at month end. Pratter calls that error-prone, with investor reports going out wrong by multiple basis points.

Fund admins face the same problem. On the centralised side there are plenty of tools. On the DeFi side, reconciling positions spread across hundreds or thousands of protocols is hard for anyone.

The cost is trust. When the tear sheets used to calculate management fees are wrong, allocators notice. That is the pain point Renesis was built to address.

Renesis now computes and publishes net asset value on-chain, starting with vaults on QMC's marketplace. QMC curates vaults for Enzyme, which Pratter describes as the largest fund tokenisation platform.

The method: data sources from fund managers using Renesis are plugged in as an NAV data source directly into the vault smart contracts. An allocator then gets a full breakdown they can verify independently on-chain, down to which transaction produced a given NAV figure.

Example given: a position bought at a point in history that appreciated in price is worth X today. Aggregated across the fund, that becomes the reported NAV. Pratter says the same approach could later extend to other DeFi vaults.

Tokenisation moves work that once needed notaries, legal services and administrators into pre-programmed smart contracts. Subscriptions, redemptions, reporting and NAV checks can happen on-chain.

Enzyme and similar fund management protocols bundle those manual steps into one ecosystem. Renesis positions itself on the reporting and NAV attestation side, helping managers get NAV audited and attested inside the vaults.

For a small fund with a solid but unverifiable record, Pratter's advice is twofold: build a network of allocators, and fix the qualitative setup so there are no red flags. Capital introduction is the usual name for that outreach.

Renesis is starting its own capital introduction and discovery platform, focused on fund investments rather than separately managed accounts. Pratter frames it as a database where allocators can find managers with a verified track record from Renesis's accounting data.

On the qualitative side it works with a rating agency called Bluechip, which grades the setup of a crypto fund. Combined, the two datasets give allocators one view to evaluate opportunities.

Pratter is clear on the limit: this only removes the first due diligence step. A direct fund investment still takes time and a relationship between allocator and manager.

Traditional markets are centralised by design: one order book, one company, one server running execution. Pratter expects more of that capital to move on-chain, citing studies of $15 trillion in assets moving on-chain by 2030.

For tokenised markets to work, the rails must match what TradFi users expect: the same feel, accounting and execution. Renesis is targeting the harder near-term case, crypto-native funds already managing DeFi portfolios.

The longer-term argument is positioning: serving those funds now means being part of on-chain capital markets later.